Report Categories
View AllRecent Articles
View All
The moat Unilever UL is building for long term dominance Selling Pressure 20260508
Design Thera DSGN Stock Trendline Analysis Q4 2025 Better Than Expected
Vanguard Information Technology ETF VGT Optimal Diversified Play for Microsoft AI Upside Amid PostEarnings Pullback
What could go wrong with Hercules HCXY stock Hercules posts 44 EPS miss vs consensus forecasts
Foreign Investors Offload Over Rs 30000 Crore in Indian Equities in May as 2026 Outflows Reach Rs 222 Lakh Crore
Argus Research Highlights LongTerm Growth Potential for Applied Materials AMAT
Spain Blocks Access to Prediction Markets Kalshi and Polymarket Over Gambling Law Concerns
Space Stocks Surge as SpaceX Starship Test Fuels PreIPO Speculation
Market Digest Highlights Lowes Aptiv and Zoetis as Stocks in Focus
Nvidia Stock Approaches Critical Technical Level Traders Eye Potential Breakout or Reversal
Hecla Mining Q1 2026 Earnings EPS Falls Short of Expectations Amid Cost Pressures
NetScout Systems NTCT Q1 2026 Earnings EPS Surpasses Estimates Amid Margin Discipline
GRRR Q4 2025 Earnings Significant EPS Miss but Stock Rises Over 12
VG Q1 2026 Earnings EPS Surges Past Estimates Stock Reacts Positively
FMX Q1 2026 Earnings Profit Falls Sharply Short of Street Estimates
Cass Information Systems Q1 2026 Earnings EPS Beat by Nearly 6 but Stock Slips on Missing Revenue Details
Catalyst Bancorp Inc CLST Edges Higher as Stock Holds Above Key Support
Alphabet Inc GOOGL Faces NearTerm Pressure Amid Broader Market Hesitation
Lexaria Bioscience LEXX Surges 733 as Biotech Momentum Builds Key Levels in Focus
NMCO Edges Higher as Nuveen Municipal Credit Fund Holds Above Support
GrabAGun Digital Holdings PEW Edges Lower Amidst Narrow Trading Range
Zentek Ltd ZTEK Edges Lower as Shares Trade Near Key Support Zone
Veeva Systems VEEV Holds Above Support After Modest Gain Cautious Trend Continues
Smurfit WestRock SW Rises 17 as Shares Approach Key Resistance Level
GRI Bio Inc GRI Posts Modest Gains as Stock Holds Above Key Support
KalVista Pharmaceuticals KALV Holds Steady Near Support as Biotech Sector Watches for Catalyst